Investing in the science behind what’s yet to come

A business built to address evolving needs

A close up of colorful lights in a dark room.

At Bayer, the work we do changes lives. We’re pursuing Science for a Better Life—not only for our stakeholders, but to benefit everyone. Our vision “Health for all, Hunger for none” articulates what we strive for.


Our mission and development strategy are one in the same. Our research addresses the trends we are all facing in the coming decades—namely supporting an aging, growing global population by providing food and healthcare to all, while also using fewer resources and fighting climate change.


By finding answers to these ongoing and evolving issues, we’re finding solutions for the many new challenges yet to come. We’re cultivating our ongoing legacy of innovation and our relentless pursuit of sustainability, to make meaningful advancements in Consumer Health, Pharmaceuticals, and Crop Science.

Driving the cutting edge of Consumer Health

More and more, people are taking charge of their health and self-care. Thanks to our ongoing innovation and investment in digitalization, we are well positioned to leverage new business opportunities developing from the growing consumer health market. To maximize our impact, we adopted a new operational model in 2019 that better enables us to provide customers with the products, services, and information they need to improve their quality of life by taking greater responsibility for their daily health. We’re accelerating organic growth across attractive categories, geographies, channels and brands and strive to transfer prescriptions and active ingredients to nonprescription status to heighten our consumer-and customer-centric approach.


Forging new paths in Pharmaceuticals

At Pharmaceuticals, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. Our R&D focuses on promising trends with great potential for improving patient well-being in therapeutic areas with a high medical need. With our innovations, we strive to enable people from all age groups “to be and do what they value throughout their lives” while aging actively and healthily. We want people to be able to share in medical progress, regardless of their income or background. To advance pharmaceutical innovation for patients and consumers while supporting access, we are collaborating with a number of partners. We will couple our scientific offering by embracing new opportunities in data science and digital technology to help us bring innovative therapies to patients and transform the way health care is delivered.


Harnessing the power of Crop Science

With a leading portfolio in corn, soybeans, cereal and horticulture, we are the largest integrated player in the agriculture industry. Our four-pronged strategy of innovation, digitalization, operational excellence and sustainability enables us to continually set and surpass new industry standards to deliver tailored solutions to farmers around the world that shape the future of agriculture. Leveraging our unsurpassed R&D platforms, our researchers deliver higher-performing seed varieties, biotech traits, chemical and biological crop protection products, and digital tools to pursue more sustainable models for accomplishing more through agriculture while also protecting our environment.


Every investment in innovation is an investment in sustainability

Our goals are ambitious—and achievable. We firmly believe that scientific discovery is the key to building a sustainable future, for our company, humanity, and our planet. As such, we are strategically investing to improve existing technologies, discover sustainable solutions, and pioneer new possibilities for all of us. We are deeply focused on operational excellence and disciplined capital allocation, which help ensure that our efforts generate the maximum positive impact.


Well positioned in attractive markets

Because innovation is the heart of everything we do, Bayer operates as a global leader in consumer health, pharmaceuticals, and Crop Science. Society will always need new solutions to harness evolving challenges and opportunities. Through strategic investments in our innovation pipeline, we’re constantly driving new possibilities for our business— and our world.

FY 2020 Divisional Market Sizes and Positions